Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: Results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study

Journal of Clinical Oncology

Volumn 19, Issue 2, 2001, Pages 488-500

  Tournade, M F ^a   Com Nougue C ^a   De Kraker, J ^a   Ludwig, R ^a   Rey, A ^a   Burgers, J M B ^a   Sandstedt, B ^a   Godzinski, J ^a   Carli, M ^a   Potter, R ^a   Zucker, J M ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; HIGH RISK POPULATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEPHRECTOMY; NEPHROBLASTOMA; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

EID: 0035863407     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.2.488     Document Type: Article

References (26)

1. Pre-operative versus post-operative radiotherapy, single versus multiple courses of actinomycin D in the treatment of Wilms' tumor. Preliminary results of a controlled clinical trial conducted by the International Society of Paediatric Oncology (SIOP)
2. Effectiveness of pre-operative chemotherapy in Wilms' tumor: Results of an International Society of Pediatric Oncology (SIOP) clinical trial
3. Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: A risk-adapted therapeutic approach in Wilms' tumor
4. The treatment of Wilms' Tumor: Results of the National Wilms' Tumor Study
5. The treatment of Wilms' tumor: Results of the Second National Wilms' Tumor Study
6. The treatment of Wilms' tumor: Results of the Third National Wilms' Tumor Study
7. Comparison between single-dose and divided dose administration of dactinomycin and doxorubicin for patients with Wilms'tumor: A report from the National Wilms' Tumor Study Group
8. Prognosis for Wilms' tumor patients with nonmetastatic disease at diagnosis: Results of the Second National Wilms' Tumor Study
9. Lymph node invasion and prognosis in nephroblastoma
10. Some problems which arise when testing the equivalence of two survival distributions
11. The treatment of children with stages II-IV anaplastic Wilms' tumor: A report from the National Wilms' Tumor Study Group
12. Ifosfamide is an active drug in Wilms' tumor: A phase II study conducted by the French Society of Pediatric Oncology
13. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
14. An approximate formula for calculating sample size for comparing two binomial distributions
15. Estimation des risques associés à des événements multiples
16. PIGAS: An interactive statistical database management system
17. Veno-occlusive disease of the liver in children treated for Wilms' tumor
18. Hepatotoxicity in patients treated according to the Nephroblastoma Trial and Study SIOP9/GPOH
19. Severe hepatic toxicity after treatment with vincristine and dactinomycin using single-dose or divided-dose schedules: A report from the National Wilms' Tumor Study
20. Results of the United Kingdom Children's Cancer Study Group First Wilms'Tumor Study
21. Rarity of surgical complications after postchemotherapy nephrectomy for nephroblastoma. Experience of the International Society of Paediatric Oncology Trial and Study "SIOP-9"
22. Surgical complications after nephrectomy for Wilms' tumor
23. Effect of duration on treatment outcome and cost of treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group
24. Radiotherapy in the SIOP (International Society of Pediatric Oncology) nephroblastoma studies: A review